ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2025

Abstract Number: 1405

A Combined Score of Syndesmophytes and Facet Joint Ankylosis Improves Sensitivity to Spinal Structural Damage Progression in Axial Spondyloarthritis

Ana Bento da Silva1, Floris A. van Gaalen1, Robert Landewé2, Manouk de Hooge3, Mary Lucy Marques4, Miranda van Lunteren1, Liese de Bruin1, Gizem Ayan5, Xenofon Baraliakos6, Monique Reijnierse7, Jürgen Braun8, Désirée Van Der Heijde1 and Sofia Ramiro9, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 5Ankara Research and Training Hospital, Ankara, Turkey, 6Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 7Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 8Ruhr-University, Bochum, Germany; and Rheumatologische Versorgungszentrum (RVZ) Steglitz, Berlin, Germany, 9Leiden University Medical Center, Bunde, Netherlands

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2025

Keywords: Imaging, Measurement Instrument, spondyloarthritis

Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The computed tomography (CT) syndesmophyte score (CTSS) has shown to be more sensitive in capturing spinal structural damage progression in axial SpA (axSpA), compared to the current gold standard, the modified Stoke Ankylosis Spondylitis Spine Score (mSASSS) (de Koning A et al, Ann Rheum Dis 2018). Additionally, assessing facet joint ankylosis (FJA) on CT seems promising in further detecting progression (Stal R et al, Rheumatology 2020). We investigated whether a score combining syndesmophytes and FJA is more sensitive than CTSS for assessing spinal damage progression in axSpA.

Methods: Data from the Sensitive Imaging in Ankylosing Spondylitis cohort were used, including axSpA patients fulfilling the modified New York criteria and with ≥1 syndesmophyte. Conventional radiography (CR) and low-dose computed tomography (ldCT) of the spine were performed at baseline and 2 years (2Y) and scored by 3 (CR) or 2 (ldCT) central readers, blinded for time order. Syndesmophytes were assessed on CR and ldCT by the mSASSS and CTSS, respectively (Figure 1). The presence of FJA was evaluated on ldCT with the facet ankylosis score (FAS) on 19 facet joints (levels C5-T2 excluded due to poor visibility). The total mSASSS, CTSS and FAS were calculated per reader at each timepoint. Three versions of a combined score of syndesmophytes and FJA were proposed and computed by adding the CTSS and FAS while giving equal weight to both components (CT facet ankylosis syndesmophyte spine score A [CTFASSS-A]), 50% (CTFASSS-B) or 100% more weight to FAS (CTFASSS-C). Change scores were calculated per reader by subtracting the baseline from the 2Y score and then averaged across readers. The number of patients with positive and negative change as well as net change >0 and >0.5 were calculated for each score and compared. The total number of new or growing syndesmophytes and new FJA were calculated per reader and then averaged across readers.

Results: Forty-eight patients were included: mean (SD) age of 49 (9.7) years, 85% male, 81% HLA-B27+. Between baseline and 2Y, progression of spinal damage was observed as assessed by all scores: mean (SD) mSASSS 18.3 (14.3) vs 20.4 (15.1), CTSS 161.6 (127.1) vs 179.5 (132.3), FAS 8.2 (9.8) vs 9.4 (10.2). CTFASSS changed from 169.8 (134.5) (CTFASSS-A), 174.0 (138.4) (CTFASSS-B) and 178.1 (142.3) (CTFASSS-C) at baseline to 188.9 (140.0), 193.6 (143.9) and 198.3 (147.9) at 2Y, respectively.After 2Y, CTFASSS-A, CTFASSS-B and CTFASSS-C detected any net change in a higher percentage of patients compared to CTSS (96% vs 83%) and, most notably, to mSASSS (96% vs 46%) and FAS (96% vs 48%) (Table 1A). Moreover, considering all 48 patients, 472 new or growing syndesmophytes and 73 new FJA were detected on ldCT, denoting that the combined score captured 1.15 times more new bone formation than CTSS (545 vs 472 new lesions) (Table 1B).

Conclusion: A combined score assessing syndesmophytes and FJA captures more spinal structural damage progression in axSpA than assessing syndesmophytes alone. With respect to sensitivity to change, all CTFASSS proposals performed similarly, with the simple addition of CTSS and FAS (CTFASSS-A) being the most straightforward approach. However, further validation will define which is the best combination.

Supporting image 1Figure 1. Schematic representation to guide the calculation of the mSASSS (A), CTSS (B), FAS (C) and CTFASSS (D)

Supporting image 2Table 1. Number of axSpA patients with spinal structural damage progression on low-dose computed tomography (n=48)


Disclosures: A. Bento da Silva: None; F. van Gaalen: AbbVie, 2, BMS, 2, Eli Lilly, 2, Jacobus Stichting, 5, MSD, 2, Novartis, 2, 5, Stichting ASAS, 5, Stichting vrienden van Sole Mio, 5, UCB, 5; R. Landewé: AbbVie/Abbott, 2, Bristol-Myers Squibb(BMS), 2, Eli Lilly, 2, Janssen, 2, Joint Imaging BV, 12, Director, Novartis, 2, Pfizer, 2, Rheumatology Consultancy BV, 12, Director, UCB, 2; M. de Hooge: UCB pharma, 2; M. Marques: Novartis, 2, 6; M. van Lunteren: None; L. de Bruin: None; G. Ayan: None; X. Baraliakos: AbbVie, 2, 5, 6, 12, Paid Instructor, Advanz, 2, 6, 12, Paid instructor, Alexion, 2, 6, 12, Paid instructor, Alphasigma, 2, 6, 12, Paid instructor, Amgen, 2, 6, 12, Paid instructor, BMS, 2, 6, 12, Paid instructor, Celgene, 6, Celltrion, 2, 5, 6, 12, Paid instructor, Cesas, 2, 6, 12, Paid instructor, Chugai, 2, 6, Clarivate, 6, 12, Paid instructor, Galapagos, 2, 6, 12, Paid instructor, J&J, 2, 6, 12, Paid instructor, Janssen, 5, Lilly, 2, 6, 12, Paid instructor, Merck, 6, MoonLake, 2, 5, 6, 12, Paid instructor, MSD, 2, Novartis, 2, 5, 6, 12, Paid instructor, Peervoice, 2, 6, 12, Paid instructor, Pfizer, 2, 6, 12, Paid instructor, Roche, 2, 6, 12, Paid instructor, Sandoz, 2, 6, 12, Paid instructor, Springer, 2, 6, 12, Paid instructor, Stada, 2, 6, 12, Paid instructor, Takeda, 2, 6, 12, Paid instructor, UCB, 2, 6, 12, Paid instructor, Zuellig, 2, 6, 12, Paid instructor; M. Reijnierse: None; J. Braun: None; D. Van Der Heijde: AbbVie, 2, Alfasigma, 2, Annals of the Rheumatic Diseases, 12, Associate editor, ArgenX, 2, Bristol Myers Squibb, 2, Eli Lilly and Company, 2, Grey-Wolf Therapeutics, 2, Imaging Rheumatology BV, 12, Director, Janssen, 2, Journal of Rheumatology, 12, Editorial board member, Novartis, 2, Pfizer, 2, RMD Open, 12, Editoral board member, Takeda, 2, UCB, 2; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, 5, Galapagos/Alfasigma, 2, 5, Janssen, 2, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Bento da Silva A, van Gaalen F, Landewé R, de Hooge M, Marques M, van Lunteren M, de Bruin L, Ayan G, Baraliakos X, Reijnierse M, Braun J, Van Der Heijde D, Ramiro S. A Combined Score of Syndesmophytes and Facet Joint Ankylosis Improves Sensitivity to Spinal Structural Damage Progression in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-combined-score-of-syndesmophytes-and-facet-joint-ankylosis-improves-sensitivity-to-spinal-structural-damage-progression-in-axial-spondyloarthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-combined-score-of-syndesmophytes-and-facet-joint-ankylosis-improves-sensitivity-to-spinal-structural-damage-progression-in-axial-spondyloarthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology